Starting on:
Mar 15, 2021
Ending on:
Mar 16, 2021
Moderator(s):
Venue:
THE KAREN HOSPITAL
Max Credits:
3 Points
Provider:
Karen Hospital
Claim Points
Mar 15, 2021
Ending on:
Mar 16, 2021
Moderator(s):
THE KAREN HOSPITAL
Max Credits:
3 Points
Provider:
Karen Hospital
Claim Points
DOCTORS JOURNAL CLUB - 16/03/2021
Starting on:
Mar 15, 2021 8:00 AM
Mar 15, 2021 8:00 AM
Ending on:
Mar 16, 2021 9:00 AM
Mar 16, 2021 9:00 AM
Venue:
THE KAREN HOSPITAL
THE KAREN HOSPITAL
Description
CARMELINA is a long-term cardiovascular outcome trial that evaluates the impact of treatment with linagliptin on CV and kidney safety for type 2 diabetes.
Objectives
To evaluate the effect of linagliptin, a selective DPP-4 inhibitor, on CV outcomes and kidney outcomes in patients with type 2 diabetes at high risk of CV and kidney events.
Presenters
-
Dr.
Mukhwana Shammah
Medical Officer
THE KAREN HOSPITAL